Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2,4-thiazolidinediones
Authors:
- Rosanna MaccariRMRosanna Maccari
- Rosaria OttanàRORosaria Ottanà
- Rosella CiurleoRCRosella Ciurleo
- Maria Gabriella VigoritaMVMaria Gabriella Vigorita
- Dietmar RakowitzDRDietmar Rakowitz
- Theodora SteindlTSTheodora Steindl
- Thierry LangerTLThierry Langer
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (14) , 3886-3893
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The role of polyol pathway in high glucose-induced endothelial cell damagesDiabetes Research and Clinical Practice, 2006
- Diabetic microvascular complications—can the presence of one predict the development of another?Journal of Diabetes and its Complications, 2006
- The burden of type 2 diabetes: are we doing enough?Diabetes & Metabolism, 2003
- The double puzzle of diabetesNature, 2003
- Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitusThe American Journal of Cardiology, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Global and societal implications of the diabetes epidemicNature, 2001
- Diabetes complications and their potential prevention: Aldose reductase inhibition and other approachesMedicinal Research Reviews, 1999
- Diabetes Complications: Why Is Glucose Potentially Toxic?Science, 1996
- Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM)Drugs, 1995